Automation can benefit pharmaceutical development by enabling the accelerated assessment of the physico-chemical characteristics of investigational new drugs utilizing high-throughput screens. Two major advantages to automation are preventing scientific staff from performing repetitive labor intensive tasks and reducing the amount of compound required for testing.